Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2013

Open Access 01-12-2013 | Research

Body composition and depressive/anxiety symptoms in overweight and obese individuals with metabolic syndrome

Authors: Erika P Guedes, Eduardo Madeira, Thiago T Mafort, Miguel Madeira, Rodrigo O Moreira, Laura MC Mendonça, Amélio F Godoy-Matos, Agnaldo J Lopes, Maria Lucia F Farias

Published in: Diabetology & Metabolic Syndrome | Issue 1/2013

Login to get access

Abstract

Background

Several studies point to a correlation between obesity and the severity of depressive and anxiety symptoms in children and adults, but there are still some controversial points about this association. The aim of this study is to investigate the relationship between body composition and the severity of anxiety/depressive symptoms in overweight and obese individuals with Metabolic Syndrome (MS).

Methods

Fifty patients, 18–50 years old, overweight or obese and with the diagnosis of MS based on the International Diabetes Federation (IDF) criteria were selected for this study. Body composition was evaluated using Dual Energy X-ray Absorptiometry (DXA). Depressive symptoms were evaluated using the Hospital Anxiety and Depression Scale (HADS-Depression) and the Beck Depression Inventory (BDI). Anxiety symptoms were evaluated using HADS-Anxiety.

Results

No correlation was found between depressive symptoms (HADS-Depression or BDI) and Body Mass Index (BMI) (r = 0.01; p = 0.94 and r = −0.12, p = 0.38; respectively), Waist Circumference (WC) (r = −0.06, p = 0.67 and r = −0.22, p = 0.12; respectively), and Waist-to-Hip Ratio (WHR) (r = −0.12, p = 0.40 and r = −0.17, p = 0.23; respectively). Additionally, no correlation was found among anxiety symptoms (HADS-Anxiety) and BMI (r = −0.15, p = 0.27), and WHR (r = −0.17, p = 0.24). In contrast, a significant correlation was found between percentage of total fat (DXA) and HADS-Depression (r = 0.34, p = 0.019) and HADS-Anxiety (r = 0.30, p = 0.039). Additionally, an inverse and strong correlation was found between lean mass (in grams) and HADS-Depression (r = −0.42, p = 0.004), HADS anxiety (r = −0.57, p < 0.0001), and BDI (r = −0.44, p = 0.026).

Conclusions

In individuals with MS, the percentage of body fat, and not central fat, BMI, WC, or WHR, was associated with an increased severity of anxiety and depressive symptoms. In contrast, total lean mass was strongly associated with fewer anxiety/depressive symptoms, suggesting that body composition might be related to psychiatric comorbidity in overweight individuals with MS.
Literature
1.
go back to reference Behn A, Ur E: The obesity epidemic and its cardiovascular consequences. Curr Opin Cardiol. 2006, 21: 353-360. 10.1097/01.hco.0000231406.84554.96.CrossRefPubMed Behn A, Ur E: The obesity epidemic and its cardiovascular consequences. Curr Opin Cardiol. 2006, 21: 353-360. 10.1097/01.hco.0000231406.84554.96.CrossRefPubMed
2.
go back to reference Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand OF, Poirier P: Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008, 28 (6): 1039-1049. 10.1161/ATVBAHA.107.159228.CrossRefPubMed Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand OF, Poirier P: Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008, 28 (6): 1039-1049. 10.1161/ATVBAHA.107.159228.CrossRefPubMed
3.
go back to reference Kalarchian MA, Marcus MD: Psychiatric comorbidity of childhood obesity. Int Rev Psychiatry. 2012, 24 (3): 241-246. 10.3109/09540261.2012.678818.CrossRefPubMed Kalarchian MA, Marcus MD: Psychiatric comorbidity of childhood obesity. Int Rev Psychiatry. 2012, 24 (3): 241-246. 10.3109/09540261.2012.678818.CrossRefPubMed
4.
go back to reference Pan A, Keum N, Okereke OI, Sun Q, Kivimaki M, Rubin RR, Hu FB: Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care. 2012, 35 (5): 1171-1180. 10.2337/dc11-2055.PubMedCentralCrossRefPubMed Pan A, Keum N, Okereke OI, Sun Q, Kivimaki M, Rubin RR, Hu FB: Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care. 2012, 35 (5): 1171-1180. 10.2337/dc11-2055.PubMedCentralCrossRefPubMed
5.
go back to reference Preiss K, Brennan L, Clarke D: A systematic review of variables associated with the relationship between obesity and depression. Obes Rev. 2013, 14 (11): 906-918. 10.1111/obr.12052.CrossRefPubMed Preiss K, Brennan L, Clarke D: A systematic review of variables associated with the relationship between obesity and depression. Obes Rev. 2013, 14 (11): 906-918. 10.1111/obr.12052.CrossRefPubMed
6.
go back to reference Luppino FS, De Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, Zitman FG: Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010, 67 (3): 220-229. 10.1001/archgenpsychiatry.2010.2.CrossRefPubMed Luppino FS, De Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, Zitman FG: Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010, 67 (3): 220-229. 10.1001/archgenpsychiatry.2010.2.CrossRefPubMed
7.
go back to reference Moreira RO, Marca KF, Appolinario JC, Coutinho WF: Increased waist circumference is associated with an increased prevalence of mood disorders and depressive symptoms in obese women. Eat Weight Disord. 2007, 12 (1): 35-40. 10.1007/BF03327770.CrossRefPubMed Moreira RO, Marca KF, Appolinario JC, Coutinho WF: Increased waist circumference is associated with an increased prevalence of mood disorders and depressive symptoms in obese women. Eat Weight Disord. 2007, 12 (1): 35-40. 10.1007/BF03327770.CrossRefPubMed
8.
go back to reference Labad J, Price JF, Strachan MW, Fowkes FG, Ding J, Deary IJ, Lee AJ, Frier BM, Seckl JR, Walker BR, Reynolds RM, Edinburgh Type 2 Diabetes Study Investigators: Edinburgh type 2 diabetes study investigators. Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetologia. 2010, 53 (3): 467-471. 10.1007/s00125-009-1628-9. Labad J, Price JF, Strachan MW, Fowkes FG, Ding J, Deary IJ, Lee AJ, Frier BM, Seckl JR, Walker BR, Reynolds RM, Edinburgh Type 2 Diabetes Study Investigators: Edinburgh type 2 diabetes study investigators. Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetologia. 2010, 53 (3): 467-471. 10.1007/s00125-009-1628-9.
9.
go back to reference Woodrow G: Body composition analysis techniques in adult and pediatric patients: how reliable are they? How useful are they clinically?. Perit Dial Int. 2007, 27 (2): S245-S249.PubMed Woodrow G: Body composition analysis techniques in adult and pediatric patients: how reliable are they? How useful are they clinically?. Perit Dial Int. 2007, 27 (2): S245-S249.PubMed
10.
go back to reference Vogelzangs N, Kritchevsky SB, Beekman AT, Newman AB, Satterfield S, Simonsick EM, Yaffe K, Harris TB, Penninx BW: Depressive symptoms and change in abdominal obesity in older persons. Arch Gen Psychiatry. 2008, 65 (12): 1386-1393. 10.1001/archpsyc.65.12.1386.PubMedCentralCrossRefPubMed Vogelzangs N, Kritchevsky SB, Beekman AT, Newman AB, Satterfield S, Simonsick EM, Yaffe K, Harris TB, Penninx BW: Depressive symptoms and change in abdominal obesity in older persons. Arch Gen Psychiatry. 2008, 65 (12): 1386-1393. 10.1001/archpsyc.65.12.1386.PubMedCentralCrossRefPubMed
12.
go back to reference Blouin K, Boivin A, Tchernof A: Androgens and body fat distribution. J Steroid BiochemMol Bio. 2008, 108 (3–5): 272-280.CrossRef Blouin K, Boivin A, Tchernof A: Androgens and body fat distribution. J Steroid BiochemMol Bio. 2008, 108 (3–5): 272-280.CrossRef
13.
go back to reference Valerio CM, Zajdenverg L, Oliveira JE, Mory PB, Moyses R, Godoy-Matos AF: Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation. Diabetol Metab Syndr. 2012, 4 (1): 40-10.1186/1758-5996-4-40. doi:10.1186/1758-5996-4-40PubMedCentralCrossRefPubMed Valerio CM, Zajdenverg L, Oliveira JE, Mory PB, Moyses R, Godoy-Matos AF: Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluation. Diabetol Metab Syndr. 2012, 4 (1): 40-10.1186/1758-5996-4-40. doi:10.1186/1758-5996-4-40PubMedCentralCrossRefPubMed
14.
go back to reference Pais-Ribeiro J, Silva I, Ferreira T, Martins A, Meneses R, Baltar M: Validation study of a Portuguese version of the hospital anxiety and depression scale. Psychol Health Med. 2007, 12 (2): 225-235. 10.1080/13548500500524088.CrossRefPubMed Pais-Ribeiro J, Silva I, Ferreira T, Martins A, Meneses R, Baltar M: Validation study of a Portuguese version of the hospital anxiety and depression scale. Psychol Health Med. 2007, 12 (2): 225-235. 10.1080/13548500500524088.CrossRefPubMed
15.
go back to reference Gorenstein C, Andrade L, Vieira Filho AH, Tung TC, Artes R: Psychometric properties of the Portuguese version of the beck depression inventory on Brazilian college students. J Clin Psychol. 1999, 55: 553-562. 10.1002/(SICI)1097-4679(199905)55:5<553::AID-JCLP3>3.0.CO;2-D.CrossRefPubMed Gorenstein C, Andrade L, Vieira Filho AH, Tung TC, Artes R: Psychometric properties of the Portuguese version of the beck depression inventory on Brazilian college students. J Clin Psychol. 1999, 55: 553-562. 10.1002/(SICI)1097-4679(199905)55:5<553::AID-JCLP3>3.0.CO;2-D.CrossRefPubMed
16.
go back to reference Ludescher B, Machann J, Eschweiler GW, Thamer C, Maenz C, Hipp A, Claussen CD, Schick F: Active depression is associated with regional adiposity in the upper abdomen and the neck. Int J Psychiatry Med. 2011, 41 (3): 271-280. 10.2190/PM.41.3.f.CrossRefPubMed Ludescher B, Machann J, Eschweiler GW, Thamer C, Maenz C, Hipp A, Claussen CD, Schick F: Active depression is associated with regional adiposity in the upper abdomen and the neck. Int J Psychiatry Med. 2011, 41 (3): 271-280. 10.2190/PM.41.3.f.CrossRefPubMed
17.
go back to reference Brown ES, Varghese FP, McEwen BS: Association of depression with medical illness: does cortisol play a role?. Biol Psychiatry. 2004, 55: 1-9.CrossRefPubMed Brown ES, Varghese FP, McEwen BS: Association of depression with medical illness: does cortisol play a role?. Biol Psychiatry. 2004, 55: 1-9.CrossRefPubMed
18.
go back to reference Wong SY, Leung JC, Leung PC, Woo J: Depressive symptoms and change in abdominal obesity in the elderly: positive or negative association?. Am J Geriatr Psychiatry. 2011, 19 (8): 730-742. 10.1097/JGP.0b013e3181ff63be.PubMedCentralCrossRefPubMed Wong SY, Leung JC, Leung PC, Woo J: Depressive symptoms and change in abdominal obesity in the elderly: positive or negative association?. Am J Geriatr Psychiatry. 2011, 19 (8): 730-742. 10.1097/JGP.0b013e3181ff63be.PubMedCentralCrossRefPubMed
19.
go back to reference Hruschka DJ, Rush EC, Brewis AA: Population differences in the relationship between height, weight, and adiposity: an application of Burton’s model. Am J Phys Anthropol. 2013, 151 (1): 68-76. 10.1002/ajpa.22258.CrossRefPubMed Hruschka DJ, Rush EC, Brewis AA: Population differences in the relationship between height, weight, and adiposity: an application of Burton’s model. Am J Phys Anthropol. 2013, 151 (1): 68-76. 10.1002/ajpa.22258.CrossRefPubMed
20.
go back to reference Rush EC, Freitas I, Plank LD: Body size, body composition and fat distribution: comparative analysis of European, Maori, Pacific Island and Asian Indian adults. Br J Nutr. 2009, 102 (4): 632-641. 10.1017/S0007114508207221.CrossRefPubMed Rush EC, Freitas I, Plank LD: Body size, body composition and fat distribution: comparative analysis of European, Maori, Pacific Island and Asian Indian adults. Br J Nutr. 2009, 102 (4): 632-641. 10.1017/S0007114508207221.CrossRefPubMed
21.
go back to reference Gubata ME, Urban N, Cowan DN, Niebuhr DW: A prospective study of physical fitness, obesity, and the subsequent risk of mental disorders among healthy young adults in army training. J Psychosom Res. 2013, 75 (1): 43-48. 10.1016/j.jpsychores.2013.04.003.CrossRefPubMed Gubata ME, Urban N, Cowan DN, Niebuhr DW: A prospective study of physical fitness, obesity, and the subsequent risk of mental disorders among healthy young adults in army training. J Psychosom Res. 2013, 75 (1): 43-48. 10.1016/j.jpsychores.2013.04.003.CrossRefPubMed
22.
go back to reference Chwastiak LA, Rosenheck RA, Kazis LE: Association of psychiatric illness and obesity, physical inactivity, and smoking among a national sample of veterans. Psychosomatics. 2011, 52: 230-236. 10.1016/j.psym.2010.12.009.PubMedCentralCrossRefPubMed Chwastiak LA, Rosenheck RA, Kazis LE: Association of psychiatric illness and obesity, physical inactivity, and smoking among a national sample of veterans. Psychosomatics. 2011, 52: 230-236. 10.1016/j.psym.2010.12.009.PubMedCentralCrossRefPubMed
23.
go back to reference Wagner G, Rabkin J, Rabkin R: Exercise as a mediator of psychological and nutritional effects of testosterone therapy in HIV + men. Med Sci Sports Exerc. 1998, 30 (6): 811-817. 10.1097/00005768-199806000-00006.CrossRefPubMed Wagner G, Rabkin J, Rabkin R: Exercise as a mediator of psychological and nutritional effects of testosterone therapy in HIV + men. Med Sci Sports Exerc. 1998, 30 (6): 811-817. 10.1097/00005768-199806000-00006.CrossRefPubMed
24.
go back to reference Wallymahmed ME, Foy P, Shaw D, Hutcheon R, Edwards RH, MacFarlane IA: Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years. Clin Endocrinol (Oxf). 1997, 47 (4): 439-446. 10.1046/j.1365-2265.1997.2801076.x.CrossRef Wallymahmed ME, Foy P, Shaw D, Hutcheon R, Edwards RH, MacFarlane IA: Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years. Clin Endocrinol (Oxf). 1997, 47 (4): 439-446. 10.1046/j.1365-2265.1997.2801076.x.CrossRef
25.
go back to reference Kim NH, Kim HS, Eun CR, Seo JA, Cho HJ, Kim SG, Choi KM, Baik SH, Choi DS, Park MH, Han C, Kim NH: Depression is associated with sarcopenia, not central obesity, in elderly korean men. J Am Geriatr Soc. 2011, 59 (11): 2062-2068. 10.1111/j.1532-5415.2011.03664.x.CrossRefPubMed Kim NH, Kim HS, Eun CR, Seo JA, Cho HJ, Kim SG, Choi KM, Baik SH, Choi DS, Park MH, Han C, Kim NH: Depression is associated with sarcopenia, not central obesity, in elderly korean men. J Am Geriatr Soc. 2011, 59 (11): 2062-2068. 10.1111/j.1532-5415.2011.03664.x.CrossRefPubMed
26.
go back to reference Kress AM, Peterson MR, Hartzell MC: Association between obesity and depressive symptoms among U.S. Military active duty service personnel, 2002. J Psychosom Res. 2013, 60 (3): 263-271.CrossRef Kress AM, Peterson MR, Hartzell MC: Association between obesity and depressive symptoms among U.S. Military active duty service personnel, 2002. J Psychosom Res. 2013, 60 (3): 263-271.CrossRef
Metadata
Title
Body composition and depressive/anxiety symptoms in overweight and obese individuals with metabolic syndrome
Authors
Erika P Guedes
Eduardo Madeira
Thiago T Mafort
Miguel Madeira
Rodrigo O Moreira
Laura MC Mendonça
Amélio F Godoy-Matos
Agnaldo J Lopes
Maria Lucia F Farias
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2013
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-5-82

Other articles of this Issue 1/2013

Diabetology & Metabolic Syndrome 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.